17-35021526-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001017368.2(RFFL):āc.436A>Gā(p.Thr146Ala) variant causes a missense change. The variant allele was found at a frequency of 0.000031 in 1,612,294 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000026 ( 1 hom., cov: 32)
Exomes š: 0.000032 ( 1 hom. )
Consequence
RFFL
NM_001017368.2 missense
NM_001017368.2 missense
Scores
1
18
Clinical Significance
Conservation
PhyloP100: 3.87
Genes affected
RFFL (HGNC:24821): (ring finger and FYVE like domain containing E3 ubiquitin protein ligase) Enables enzyme binding activity; p53 binding activity; and ubiquitin protein ligase activity. Involved in cellular protein metabolic process; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis; and negative regulation of signal transduction. Located in endosome membrane and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.029614061).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RFFL | NM_001017368.2 | c.436A>G | p.Thr146Ala | missense_variant | 3/7 | ENST00000394597.7 | NP_001017368.1 | |
RAD51L3-RFFL | NR_037714.1 | n.656-4946A>G | intron_variant, non_coding_transcript_variant | |||||
RFFL | NR_037713.2 | n.566A>G | non_coding_transcript_exon_variant | 3/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RFFL | ENST00000394597.7 | c.436A>G | p.Thr146Ala | missense_variant | 3/7 | 1 | NM_001017368.2 | ENSP00000378096 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152116Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
4
AN:
152116
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000762 AC: 19AN: 249284Hom.: 0 AF XY: 0.0000668 AC XY: 9AN XY: 134716
GnomAD3 exomes
AF:
AC:
19
AN:
249284
Hom.:
AF XY:
AC XY:
9
AN XY:
134716
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000315 AC: 46AN: 1460060Hom.: 1 Cov.: 32 AF XY: 0.0000275 AC XY: 20AN XY: 726300
GnomAD4 exome
AF:
AC:
46
AN:
1460060
Hom.:
Cov.:
32
AF XY:
AC XY:
20
AN XY:
726300
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152234Hom.: 1 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74428
GnomAD4 genome
AF:
AC:
4
AN:
152234
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
74428
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
13
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 19, 2024 | The c.436A>G (p.T146A) alteration is located in exon 3 (coding exon 2) of the RFFL gene. This alteration results from a A to G substitution at nucleotide position 436, causing the threonine (T) at amino acid position 146 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;.;T;T;T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
.;T;.;.;T;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;L;L;L;L;.
MutationTaster
Benign
D;D;D;D;D;D;D;D
PrimateAI
Benign
T
PROVEAN
Benign
N;.;N;.;N;N;.
REVEL
Benign
Sift
Benign
T;.;T;.;T;T;.
Sift4G
Benign
T;T;T;T;T;T;D
Polyphen
B;P;B;B;B;P;.
Vest4
MutPred
Loss of phosphorylation at T146 (P = 0.0089);Loss of phosphorylation at T146 (P = 0.0089);Loss of phosphorylation at T146 (P = 0.0089);Loss of phosphorylation at T146 (P = 0.0089);Loss of phosphorylation at T146 (P = 0.0089);Loss of phosphorylation at T146 (P = 0.0089);Loss of phosphorylation at T146 (P = 0.0089);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at